Related Experiment Video
Updated: Nov 3, 2025

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
Published on: June 16, 2023
Long non‑coding RNA SNHG20 promotes cell proliferation, migration and invasion in retinoblastoma via the
1Department of Ophthalmology, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu 222000, P.R. China.
Abstract:
Current therapies for retinoblastoma (RB) are unsatisfactory and there is an urgent need for the development of new treatment modalities. Small nucleolar RNA host gene 20 (SNHG20) has been reported to serve a key oncogenic role in the development of various types of cancer, but its role in RB tumorigenesis remains to be fully determined. The present study aimed to investigate the expression patterns and biological roles of SNHG20 in RB. The expression levels of SNHG20 were measured via reverse transcription‑quantitative PCR in RB tissues and cell lines. The impact of SNHG20 status on cell proliferation, survival, migration and invasion was determined using small interfering RNA and a range of established experimental assays. The SNHG20/microRNA (miR)‑335‑5p/E2F transcription factor 3 (E2F3) signaling axis was further investigated using a dual‑luciferase activity reporter system and an RNA pull‑down assay combined with bioinformatics analyses. SNHG20 expression was significantly increased in RB tissues and cell lines. Silencing of SNHG20 in RB cells was shown to inhibit cell proliferation, clonogenic survival, migration and invasion. Moreover, mechanistic investigations demonstrated that SNHG20 could enhance the expression of E2F3 by sponging of miR‑335‑5p. These data suggested that the long non‑coding RNA SNHG20 may promote cell proliferation, migration and invasion in RB via the miR‑335‑5p/E2F3 axis.
Insights
Small nucleolar RNA host gene 20 (SNHG20) promotes retinoblastoma (RB) cell growth and spread. Targeting SNHG20 may offer new therapeutic strategies for this eye cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Current retinoblastoma (RB) treatments are insufficient, necessitating novel therapeutic approaches.
- The oncogenic role of Small Nucleolar RNA Host Gene 20 (SNHG20) in various cancers is known, but its function in RB tumorigenesis requires elucidation.
Purpose of the Study:
- To investigate the expression patterns and biological functions of SNHG20 in retinoblastoma.
- To explore the underlying molecular mechanisms, including the SNHG20/microRNA (miR)-335-5p/E2F transcription factor 3 (E2F3) signaling axis.
Main Methods:
- SNHG20 expression was quantified using reverse transcription-quantitative PCR in RB tissues and cell lines.
- Functional assays (proliferation, survival, migration, invasion) were performed using small interfering RNA targeting SNHG20.
- Molecular mechanisms were investigated via dual-luciferase reporter assays, RNA pull-down assays, and bioinformatics analyses.
Main Results:
- SNHG20 expression was significantly elevated in RB tissues and cell lines.
- Silencing SNHG20 suppressed RB cell proliferation, clonogenic survival, migration, and invasion.
- SNHG20 was found to upregulate E2F3 expression by sponging miR-335-5p.
Conclusions:
- The long non-coding RNA SNHG20 promotes proliferation, migration, and invasion in retinoblastoma.
- The SNHG20/miR-335-5p/E2F3 axis represents a potential therapeutic target for RB treatment.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Negative Regulator Molecules
